Strategies for discontinuing vasopressin and norepinephrine during the recovery phase of shock: a single-center retrospective study

Abstract Background The optimal strategy for discontinuing arginine vasopressin and norepinephrine in patients recovering from shock remains uncertain. Although prior studies have suggested a higher risk of hypotension when arginine vasopressin is discontinued first, these findings may have been inf...

Full description